RBP1

RBP1 (retinoblastoma binding protein 1, also known as ARID4A) functions as a transcriptional co-repressor that bridges pRB-family pocket proteins to chromatin-modifying complexes, thereby controlling E2F-dependent gene expression and cell cycle progression. RBP1 binds the pRB pocket via an LXCXE-like motif and recruits a stable mSIN3–SAP30–HDAC1/2/3 complex through its R2 domain, while its R1 region contributes HDAC-independent repression activities including a SUMOylation-dependent module; together these domains are required for growth suppression and senescence induction (PMID:10490602, PMID:11283269, PMID:16479010). CDK2-mediated phosphorylation of RBP1 at S864 and S1007 during the G1-to-S transition destabilizes the RBP1–pRb interaction, releasing the mSin3–HDAC complex to alleviate transcriptional repression (PMID:21148318). SIRT1, recruited to the R2 domain through ING1b/ING2 subunits of the mSIN3A/HDAC1 complex, negatively modulates R2-mediated repression, revealing cross-regulation between class I and class III HDACs at RBP1-containing complexes (PMID:18193082).

1. 1993 High

   Identification of RBP1 as a direct pRB-interacting nuclear phosphoprotein established it as a candidate effector of pRB-mediated growth control, with HPV E7 competition demonstrating the biological relevance of the pocket interaction.

   Evidence cDNA cloning, in vivo co-IP, E7 competition assay in multiple cell lines

   PMID:8414517 PMID:8455946

   Open questions at the time

   • Mechanism by which RBP1 contributes to pRB-mediated growth suppression was unknown
   • Functional consequence of alternative splicing isoforms not determined
   • Whether RBP1 contacts other pocket-family proteins was not tested
2. 1999 High

   Discovery that RBP1 possesses separable HDAC-dependent and HDAC-independent repression domains, and associates with pRB/p130–E2F complexes during growth arrest, established RBP1 as a bona fide transcriptional co-repressor mediating pocket protein function at E2F target genes.

   Evidence Domain deletion/reporter assays, co-IP of RBP1–pRB/p130–E2F complexes, cell growth inhibition upon overexpression

   PMID:10321733 PMID:10490602

   Open questions at the time

   • Identity of the HDAC complex recruited by RBP1 was not resolved
   • Mechanism of the HDAC-independent repression domain remained undefined
   • In vivo genomic targets of RBP1-containing complexes were not mapped
3. 2001 High

   Biochemical purification of a stable RBP1–mSIN3–SAP30–HDAC complex that accounts for the majority of pRB-associated HDAC activity, and its co-localization with RB-family/E2F4 at DNA replication origins in quiescent cells, defined the molecular identity and subnuclear organization of the RBP1 repression module.

   Evidence Stable complex purification with mass spectrometry, immunofluorescence co-localization in primary human cells

   PMID:11283269

   Open questions at the time

   • Whether RBP1 is required for repression at replication origins was not tested by loss-of-function
   • Structural basis of RBP1–mSIN3–SAP30 assembly not determined
   • BRMS1 integration into the complex (later discovered) was not known
4. 2003 Medium

   Identification of BRMS1 as an RBP1-interacting subunit that co-immunoprecipitates with at least seven mSin3–HDAC components expanded the composition of the RBP1-nucleated repression complex and linked it to metastasis suppression.

   Evidence Yeast two-hybrid screen, reciprocal co-IP, HDAC activity assay, Gal4-tethered repression assay

   PMID:14581478

   Open questions at the time

   • Whether BRMS1 modulates RBP1-mediated repression at endogenous E2F targets not tested
   • Stoichiometry and direct vs. bridged contact between BRMS1 and RBP1 unclear
5. 2006 High

   Fine mapping of the R1 region revealed a SUMOylation-dependent repression module (R1σ) and an ARID-embedded basal repression activity (R1α), and showed that full growth suppression and senescence induction require both R1 and R2 domains, demonstrating that RBP1 integrates at least three mechanistically distinct repression pathways.

   Evidence Domain deletion/mutation, SUMOylation assays, transcription reporter assays, SA-β-galactosidase senescence assay

   PMID:16479010

   Open questions at the time

   • Identity of SUMO-recruited effectors at R1σ not determined
   • Whether the ARID domain binds DNA in the context of RBP1 function not resolved
   • Relative contributions of R1 vs R2 at endogenous loci unknown
6. 2008 Medium

   Demonstration that SIRT1, recruited via ING1b/ING2, interacts with and negatively regulates R2-mediated HDAC-dependent repression established a feedback layer in which class III HDAC activity antagonizes class I HDAC repression at RBP1-containing complexes.

   Evidence In vitro/in vivo binding assays, resveratrol/sirtinol pharmacological modulation of reporter repression

   PMID:18193082

   Open questions at the time

   • Molecular target of SIRT1 deacetylation within the complex not identified
   • Physiological context (cell cycle phase, differentiation) of SIRT1 regulation not defined
   • Relies on pharmacological activators/inhibitors with known off-target effects
7. 2010 High

   Identification of CDK2-mediated phosphorylation of RBP1 at S864 and S1007 as the cell-cycle-regulated switch that dissociates RBP1 from pRb at G1/S provided a mechanistic explanation for how the mSin3–HDAC complex is released from pocket proteins to permit E2F target gene activation.

   Evidence In vitro kinase reconstitution, site-directed mutagenesis, synchronized MCF-7 co-IP

   PMID:21148318

   Open questions at the time

   • Fate of the released RBP1–mSin3–HDAC complex after dissociation from pRb not tracked
   • Whether phospho-RBP1 is targeted for degradation or re-docking in the next cycle is unknown
   • In vivo confirmation using phospho-dead knock-in not performed
8. 2010 Medium

   Discovery of a coactivator role for RBP1 in Runx2-driven osteoblast differentiation revealed a context-dependent activating function distinct from its canonical co-repressor activity.

   Evidence shRNA knockdown in osteoblasts, mineralization assays, qPCR, Runx2 P2 promoter reporter

   PMID:20509905

   Open questions at the time

   • Mechanism by which RBP1 switches from repressor to coactivator not defined
   • Whether the ARID domain or other domains mediate Runx2 interaction not mapped
   • Not independently replicated

• Key unresolved questions include the structural basis of the RBP1–mSin3–SAP30 assembly, the identity of SUMO-recruited effectors at R1σ, genome-wide target gene mapping of RBP1-containing complexes, and the mechanism underlying RBP1's context-dependent switch between repressor and coactivator functions.
• No structural model of the RBP1-containing repression complex exists
• No genome-wide ChIP-seq or CUT&RUN map of RBP1 occupancy reported
• In vivo genetic models (knockout/knock-in) characterizing physiological roles are absent from the timeline